Pictet Asset Management (Switzerland)’s Aurinia Pharmaceuticals AUPH Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$120K	Hold	12,415	–	–	﹤0.01%	1826
2023 Q1	$136K	Sell	12,415 -6,460	-34%	-$56.9K	﹤0.01%	1815
2022 Q4	$82K	Buy	+18,875	New	+$110K	﹤0.01%	1901
2022 Q1	–	Sell	-1,449,624	Closed	-$33.2M	–	1688
2021 Q4	$33.2M	Buy	1,449,624 +433,205	+43%	+$10.3M	0.03%	419
2021 Q3	$22.5M	Buy	+1,016,419	New	+$16.1M	0.02%	490

Other funds holding AUPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s AUPH Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) held its Aurinia Pharmaceuticals (AUPH) position steady in Q2 2023 at 12,415 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #1826.

Pictet Asset Management (Switzerland) first reported a position in AUPH in Q3 2021 and has held it in 5 quarters since. The position peaked at $33.2M in Q4 2021. 200 funds tracked by Wall St. Rank hold AUPH as of Q2 2023.

Pictet Asset Management (Switzerland) held 12,415 shares of Aurinia Pharmaceuticals worth $120K as of Q2 2023.
Pictet Asset Management (Switzerland) left its Aurinia Pharmaceuticals share count unchanged in Q2 2023.
Aurinia Pharmaceuticals made up ﹤0.01% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #1826 holding.
Pictet Asset Management (Switzerland) first reported a position in Aurinia Pharmaceuticals in Q3 2021 and has held it in 5 quarters since.
Pictet Asset Management (Switzerland)'s Aurinia Pharmaceuticals position peaked at $33.2M in Q4 2021.
200 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.